Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1037.HK Stock Summary
In the News
1037.HK Financial details
Company Rating
Neutral
Market Cap
235.02M
Income
56.3M
Revenue
1.52B
Book val./share
0.67
Cash/share
0.19
Dividend
-
Dividend %
-
Employees
567
Optionable
No
Shortable
Yes
Earnings
26 Mar 2024
P/E
4.02
Forward P/E
-
PEG
0.65
P/S
0.13
P/B
0.25
P/C
1.58
P/FCF
5.31
Quick Ratio
0.61
Current Ratio
2.2
Debt / Equity
0.02
LT Debt / Equity
0
-
-
EPS (TTM)
0.08
EPS next Y
-
EPS next Q
-
EPS this Y
-19.96%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
78.35%
Revenue last 5Y
20.61%
Revenue Q/Q
-25.27%
EPS Q/Q
-73.53%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
4%
ROE
6%
ROC
0.07%
Gross Margin
15%
Oper. Margin
4%
Profit Margin
3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.138-0.445
52W High
-
52W Low
-
RSI
47
Rel Volume
0.03
Avg Volume
449.62K
Volume
14K
Perf Week
-6.25%
Perf Month
20.97%
Perf Quarter
42.86%
Perf Half Y
40.85%
-
-
-
-
Beta
-0.033
-
-
Volatility
0.01%, 0.05%
Prev Close
-6.25%
Price
0.3
Change
-9.09%
1037.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.49 | 0.66 | 0.8 | 0.86 | 1.19 | |
Net income per share | 0 | 0.02 | 0.02 | 0.05 | 0.04 | |
Operating cash flow per share | -0.04 | 0.12 | 0.08 | 0.02 | 0.03 | |
Free cash flow per share | -0.04 | 0.12 | 0.08 | 0.02 | 0.03 | |
Cash per share | 0.21 | 0.28 | 0.32 | 0.27 | 0.24 | |
Book value per share | 0.5 | 0.52 | 0.54 | 0.6 | 0.64 | |
Tangible book value per share | 0.49 | 0.52 | 0.54 | 0.57 | 0.62 | |
Share holders equity per share | 0.5 | 0.52 | 0.54 | 0.6 | 0.64 | |
Interest debt per share | 0 | 0 | 0.05 | 0.03 | 0.01 | |
Market cap | 429.75M | 289.5M | 270.02M | 211.58M | 154.88M | |
Enterprise value | 289.61M | 105.71M | 86.97M | 44.54M | -2.49M | |
P/E ratio | 298.44 | 25.01 | 18.45 | 6.18 | 5.57 | |
Price to sales ratio | 1.32 | 0.67 | 0.52 | 0.35 | 0.19 | |
POCF ratio | -18.03 | 3.59 | 5.09 | 14.05 | 7.02 | |
PFCF ratio | -15.88 | 3.74 | 5.31 | 18.85 | 7.62 | |
P/B Ratio | 1.3 | 0.84 | 0.76 | 0.51 | 0.34 | |
PTB ratio | 1.3 | 0.84 | 0.76 | 0.51 | 0.34 | |
EV to sales | 0.89 | 0.25 | 0.17 | 0.07 | 0 | |
Enterprise value over EBITDA | 13.92 | 5.1 | 1.78 | 1.06 | -0.05 | |
EV to operating cash flow | -12.15 | 1.31 | 1.64 | 2.96 | -0.11 | |
EV to free cash flow | -10.7 | 1.36 | 1.71 | 3.97 | -0.12 | |
Earnings yield | 0 | 0.04 | 0.05 | 0.16 | 0.18 | |
Free cash flow yield | -0.06 | 0.27 | 0.19 | 0.05 | 0.13 | |
Debt to equity | 0 | 0 | 0.08 | 0.05 | 0.02 | |
Debt to assets | 0 | 0 | 0.05 | 0.03 | 0.01 | |
Net debt to EBITDA | -6.74 | -8.86 | -3.74 | -3.99 | -3.27 | |
Current ratio | 3.51 | 2.73 | 2.75 | 2.43 | 2.2 | |
Interest coverage | 0 | 0 | 23.59 | 23.53 | 63.03 | |
Income quality | -16.55 | 6.96 | 2.37 | 0.4 | 0.72 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.16 | 0.12 | 0.09 | 0.08 | 0.06 | |
Research and developement to revenue | 0 | 0.01 | 0.02 | 0.03 | 0.01 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0.03 | 0.02 | |
Capex to operating cash flow | 0.14 | -0.04 | -0.04 | -0.25 | -0.08 | |
Capex to revenue | -0.01 | -0.01 | 0 | -0.01 | 0 | |
Capex to depreciation | -0.32 | -0.16 | -0.11 | -0.18 | -0.09 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.02 | 0 | |
Graham number | 0.16 | 0.46 | 0.52 | 0.82 | 0.76 | |
ROIC | 0 | 0.03 | 0.05 | 0.04 | 0.06 | |
Return on tangible assets | 0 | 0.02 | 0.03 | 0.06 | 0.04 | |
Graham Net | 0.27 | 0.25 | 0.27 | 0.22 | 0.2 | |
Working capital | 271.26M | 269.57M | 287.27M | 307.65M | 325.16M | |
Tangible asset value | 327.22M | 341.1M | 353.53M | 392.84M | 434.48M | |
Net current asset value | 251.72M | 241.18M | 270.17M | 293.85M | 321.61M | |
Invested capital | 0 | 0 | 0.08 | 0.05 | 0.02 | |
Average receivables | 216.4M | 199.5M | 190.75M | 182.48M | 207.76M | |
Average payables | 84.29M | 79.72M | 103.67M | 112.96M | 144.7M | |
Average inventory | 24.48M | 27.74M | 26.95M | 66.65M | 129.34M | |
Days sales outstanding | 223.21 | 168.97 | 126.9 | 112 | 101.96 | |
Days payables outstanding | 103.35 | 105.97 | 88.98 | 91.82 | 86.98 | |
Days of inventory on hand | 45.1 | 31.7 | 19.72 | 83.35 | 76.88 | |
Receivables turnover | 1.64 | 2.16 | 2.88 | 3.26 | 3.58 | |
Payables turnover | 3.53 | 3.44 | 4.1 | 3.98 | 4.2 | |
Inventory turnover | 8.09 | 11.51 | 18.51 | 4.38 | 4.75 | |
ROE | 0 | 0.03 | 0.04 | 0.08 | 0.06 | |
Capex per share | 0 | 0 | 0 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.38 | 0.48 | 0.51 | 0.67 | 0.5 | |
Net income per share | 0.02 | 0.03 | 0.01 | 0.03 | 0.01 | |
Operating cash flow per share | -0.05 | 0.07 | -0.02 | 0.06 | -0.04 | |
Free cash flow per share | -0.05 | 0.06 | -0.03 | 0.06 | -0.04 | |
Cash per share | 0.25 | 0.27 | 0.21 | 0.24 | 0.19 | |
Book value per share | 0.56 | 0.59 | 0.61 | 0.64 | 0.67 | |
Tangible book value per share | 0.53 | 0.56 | 0.58 | 0.62 | 0.64 | |
Share holders equity per share | 0.56 | 0.59 | 0.61 | 0.64 | 0.67 | |
Interest debt per share | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | |
Market cap | 255.12M | 214.71M | 176.65M | 154.88M | 155.6M | |
Enterprise value | 106.02M | 47.67M | 43.68M | -2.49M | 27.82M | |
P/E ratio | 5.55 | 2.36 | 6.96 | 1.8 | 6.83 | |
Price to sales ratio | 0.99 | 0.64 | 0.49 | 0.33 | 0.44 | |
POCF ratio | -8.2 | 4.65 | -10.5 | 3.98 | -5.39 | |
PFCF ratio | -7.92 | 4.75 | -9.67 | 4.01 | -5.19 | |
P/B Ratio | 0.67 | 0.52 | 0.42 | 0.34 | 0.33 | |
PTB ratio | 0.67 | 0.52 | 0.42 | 0.34 | 0.33 | |
EV to sales | 0.41 | 0.14 | 0.12 | -0.01 | 0.08 | |
Enterprise value over EBITDA | 6.1 | 8.72 | 3.99 | -0.11 | 1.94 | |
EV to operating cash flow | -3.41 | 1.03 | -2.6 | -0.06 | -0.96 | |
EV to free cash flow | -3.29 | 1.05 | -2.39 | -0.06 | -0.93 | |
Earnings yield | 0.05 | 0.11 | 0.04 | 0.14 | 0.04 | |
Free cash flow yield | -0.13 | 0.21 | -0.1 | 0.25 | -0.19 | |
Debt to equity | 0.06 | 0.05 | 0.04 | 0.02 | 0.02 | |
Debt to assets | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | |
Net debt to EBITDA | -8.58 | -30.54 | -12.16 | -7.19 | -8.91 | |
Current ratio | 2.69 | 2.43 | 2.38 | 2.2 | 2.86 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -2.71 | 2.03 | -2.65 | 1.81 | -5.07 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.09 | 0.07 | 0.06 | 0.07 | 0.07 | |
Research and developement to revenue | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | |
Intangibles to total assets | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | |
Capex to operating cash flow | 0.04 | -0.02 | 0.09 | -0.01 | 0.04 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.11 | -0.09 | -0.14 | -0.04 | -0.13 | |
Stock based compensation to revenue | 0 | 0.03 | 0 | 0 | 0 | |
Graham number | 0.46 | 0.66 | 0.35 | 0.67 | 0.35 | |
ROIC | 0.02 | 0 | 0.01 | 0.04 | 0.01 | |
Return on tangible assets | 0.02 | 0.04 | 0.01 | 0.03 | 0.01 | |
Graham Net | 0.24 | 0.22 | 0.19 | 0.2 | 0.23 | |
Working capital | 303.94M | 307.65M | 308.28M | 325.16M | 346.83M | |
Tangible asset value | 362.11M | 392.84M | 406.66M | 434.48M | 452.19M | |
Net current asset value | 291.97M | 293.85M | 300.84M | 321.61M | 342.79M | |
Invested capital | 0.06 | 0.05 | 0.04 | 0.02 | 0.02 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 70.72 | 48.75 | 50.54 | 44.2 | 50.26 | |
Days payables outstanding | 49.32 | 39.7 | 44.1 | 37.76 | 35.31 | |
Days of inventory on hand | 27.13 | 36.04 | 36.77 | 33.37 | 40.79 | |
Receivables turnover | 1.27 | 1.85 | 1.78 | 2.04 | 1.79 | |
Payables turnover | 1.82 | 2.27 | 2.04 | 2.38 | 2.55 | |
Inventory turnover | 3.32 | 2.5 | 2.45 | 2.7 | 2.21 | |
ROE | 0.03 | 0.06 | 0.01 | 0.05 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1037.HK Frequently Asked Questions
What is Maxnerva Technology Services Limited stock symbol ?
Maxnerva Technology Services Limited is a HK stock and trading under the symbol 1037.HK
What is Maxnerva Technology Services Limited stock quote today ?
Maxnerva Technology Services Limited stock price is $0.3 today.
Is Maxnerva Technology Services Limited stock public?
Yes, Maxnerva Technology Services Limited is a publicly traded company.